CN1223374C - Chinese medicinal composition for treating hepatitis B - Google Patents
Chinese medicinal composition for treating hepatitis B Download PDFInfo
- Publication number
- CN1223374C CN1223374C CN 200410014021 CN200410014021A CN1223374C CN 1223374 C CN1223374 C CN 1223374C CN 200410014021 CN200410014021 CN 200410014021 CN 200410014021 A CN200410014021 A CN 200410014021A CN 1223374 C CN1223374 C CN 1223374C
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- root
- hepatitis
- grams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000002672 hepatitis B Diseases 0.000 title claims abstract description 29
- 239000000203 mixture Substances 0.000 title claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 235000014375 Curcuma Nutrition 0.000 claims abstract description 4
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 4
- 239000000463 material Substances 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 29
- 238000011282 treatment Methods 0.000 claims description 26
- 239000007788 liquid Substances 0.000 claims description 23
- 239000000843 powder Substances 0.000 claims description 15
- 241000756943 Codonopsis Species 0.000 claims description 9
- 239000009636 Huang Qi Substances 0.000 claims description 9
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 5
- 239000012535 impurity Substances 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 241000407170 Curcuma Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 24
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 210000004185 liver Anatomy 0.000 abstract description 3
- 244000061520 Angelica archangelica Species 0.000 abstract description 2
- 244000025254 Cannabis sativa Species 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 241000283690 Bos taurus Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 241000510667 Conioselinum Species 0.000 abstract 1
- 244000164480 Curcuma aromatica Species 0.000 abstract 1
- 244000150195 Cyperus longus Species 0.000 abstract 1
- 235000018109 Cyperus longus Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000017443 Hedysarum boreale Nutrition 0.000 abstract 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000294611 Punica granatum Species 0.000 abstract 1
- 235000014360 Punica granatum Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 240000007164 Salvia officinalis Species 0.000 abstract 1
- 244000058416 Scirpus paludosus Species 0.000 abstract 1
- 235000005010 Scirpus paludosus Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 235000005272 common selfheal Nutrition 0.000 abstract 1
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 abstract 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 abstract 1
- 235000005412 red sage Nutrition 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000000840 anti-viral effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
- 241000205571 Caulophyllum Species 0.000 description 2
- 208000034657 Convalescence Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 101710173228 Glutathione hydrolase proenzyme Proteins 0.000 description 2
- 241000700721 Hepatitis B virus Species 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 241001290610 Abildgaardia Species 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010059193 Acute hepatitis B Diseases 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 244000163122 Curcuma domestica Species 0.000 description 1
- 240000009138 Curcuma zedoaria Species 0.000 description 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 101710107035 Gamma-glutamyltranspeptidase Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 208000037262 Hepatitis delta Diseases 0.000 description 1
- 241000724709 Hepatitis delta virus Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000219050 Polygonaceae Species 0.000 description 1
- 101710098398 Probable alanine aminotransferase, mitochondrial Proteins 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000037628 acute hepatitis B virus infection Diseases 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- WGXUDTHMEITUBO-YFKPBYRVSA-N glutaurine Chemical compound OC(=O)[C@@H](N)CCC(=O)NCCS(O)(=O)=O WGXUDTHMEITUBO-YFKPBYRVSA-N 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 235000019509 white turmeric Nutrition 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention relates to a Chinese medicinal composition for treating viral hepatitis B which takes raw medicinal materials of raw milkvetch root, radix codonopsitis, stir-baked largehead atractylodes rhizome, angelica, white peony root, nutgrass galingale rhizome, rehmannia root, hemlock parsley, red sage root, curcuma root, red paeony root, common selfheal fruit-spike, lalang grass rhizome, baical skullcap root, giant knotweed rhizome, pomegranate rind and raw licorice root which are mixed according to a reasonable proportion, and decocted by adding a right amount of water. The present invention for treating viral hepatitis B has high effective rate, high cure rate and no toxic or side effect. After the present invention is orally taken, liver qi, qi and blood are soothed, and the present invention is suitable for treating patients with various kinds of hepatitis B.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of hepatitis B, specifically a kind of Chinese medicine composition for the treatment of hepatitis B.
Background technology
Hepatitis B is modal a kind of in the viral hepatitis.According to the statistics made by the departments concerned, more than China's hepatitis B virus carriers was up to 100,000,000 people, hepatitis B patient had more than 2,000 ten thousand people.Hepatitis B has characteristics such as strong, popular wide, the sickness rate height of infectiousness, and virus is survived in human body and constantly duplicated, and makes the state of an illness be easy to chronicity.In addition, hepatitis B patient and virus carrier also are very easy to be subjected to the invasion and attack of hepatitis D virus, cause concurrent infection, make the aggravation of hepatitis B symptom, and sb.'s illness took a turn for the worse, causes acute severe hepatitis or liver cirrhosis etc.
5 inspections of hepatitis b virus marker are: 1, surface antigen; 2, surface antibody; 3, e antigen; 4, e antibody; 5, core antibody.If wherein the 1,3, the 5th, positive, just cry " great three positive "; Wherein the 1,4, the 5th, positive just cry " small three positive ".
At present, doctor trained in Western medicine is provided with treatment hepatitis B specific drug clinically, takes the therapy of some antiviral of very not suiting the medicine to the illness and enhance immunity usually, and effect is all undesirable; The traditional Chinese medical science produces many proved recipes in the treatment hepatitis B, ignore but the Chinese medicine preparation that is adopted stresses eliminating evil mostly and to set upright name side, what have goes back toxic side effect, the patient is not felt well, the more important thing is that the patient to different syndromes lacks adaptability, thereby most unsatisfactory curative effect.
Summary of the invention
The objective of the invention is in above-mentioned, the defective that exists of Western medicine, provide a kind of eliminating pathogenic factor for supporting vital QI to develop simultaneously to people, to foster healthy energy, effective conditioning human body internal organs QI and blood balance, strengthen resistance of human body, the Chinese medicine composition of the treatment hepatitis B that effective percentage that the acceleration antiviral antibody produces and cure rate are higher.
Technical solution of the present invention:
1, Chinese medicine composition of the present invention is made (consumption is a weight portion) by following raw materials according
Radix Astragali 10～30 Radix Codonopsis 10～30 Rhizoma Atractylodis Macrocephalae (parched)s 10～15 Radix Angelicae Sinensis 10～15
Radix Paeoniae Alba 10～15 Rhizoma Cyperis 10～15 Radix Rehmanniae 10～30 Rhizoma Chuanxiongs 3～10
Radix Salviae Miltiorrhizae 5～15 Radix Curcumaes 6～12 Radix Paeoniae Rubras 3～15 Spica Prunellaes 10～15
Rhizoma Imperatae 15～30 Radix Scutellariaes 3～10 Rhizoma Polygoni Cuspidati 10～30 Pericarpium Granatis 10～15
Radix Glycyrrhizae 2～10.
2, the production method of above-mentioned each raw material being made Chinese medicine composition of the present invention is:
(1) each material medicine is removed impurity;
(2) described mixed adds water and crosses powder and decoct, and heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid and leaches;
(3) recrement adds water and crosses powder and decoct, and heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid and leaches;
(4) the secondary recrement adds water and crosses powder and decoct, and heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid and leaches;
(5) medicinal liquid that leaches for three times is mixed, get final product.
The present invention is on the basis of summing up forefathers' Chinese traditional treatment hepatitis B, and by the drug screening of several years and clinical verification repeatedly, elaborate combination forms, the effect of each raw material of the present invention:
Selecting for use Radix Astragali, Radix Codonopsis, Rhizoma Atractylodis Macrocephalae (parched) as monarch drug, is for air making-up and spleen enlivening, fosters healthy energy.Because the Radix Astragali is the dry root of the bean tannin plant Radix Astragali or Inner Mongolia Astragalis etc., sweet, the tepor of nature and flavor has tonifying Qi and lifting yang, and benefit is defended consolidating superficial resistance, effects such as inducing diuresis to remove edema; Radix Codonopsis is the root of campanulaceae plant Radix Codonopsis, and nature and flavor are sweet flat, have invigorating the spleen and replenishing QI, the effect such as nourish blood of promoting the production of body fluid; The Rhizoma Atractylodis Macrocephalae is a feverfew Rhizoma Atractylodis Macrocephalae rhizome, and property bitter but sweet flavor, temperature have air making-up and spleen enlivening, dampness diuretic, function such as hidroschesis is antiabortive.
Selecting for use Radix Angelicae Sinensis, Radix Paeoniae Alba, Rhizoma Cyperi, the Radix Rehmanniae and Rhizoma Chuanxiong as ministerial drug, is for QI and blood regulating, rises and enriches blood the effect of invigorating blood circulation and nourish blood.Because when being classified as the root of umbelliferae angelica, the sweet suffering of nature and flavor, temperature, have enrich blood, invigorate blood circulation, pain relieving, purging and intestine lubricating action; Radix Paeoniae Alba is the root of cohosh Radix Paeoniae, nature and flavor hardship, acid, is slightly cold, and has the yin fluid astringing of nourishing blood, easing the affected liver to relieve pain, functions such as suppressing liver-YANG; Rhizoma Cyperi is a sedge dried tuber rhizome, and nature and flavor suffering, little hardship are sweet, flat, have depressed liver-energy dispersing and QI regulating, effects such as menstruction regulating and pain relieving; Radix Rehmanniae is the tuber of ginseng section plant Radix Rehmanniae, and nature and flavor are sweet, bitter, cold, have clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting, effects such as intestine moistening; Rhizoma Chuanxiong is the root of samphire Rhizoma Chuanxiong, and property and flavor of peppery and warm has blood-activating and qi-promoting, effects such as wind-expelling pain-stopping.
Select Radix Salviae Miltiorrhizae for use, Radix Curcumae, Radix Paeoniae Rubra, Spica Prunellae and Rhizoma Imperatae are for removing heat from blood as adjuvant drug, the liver-fire that disappears, blood circulation promoting and blood stasis dispelling, dampness removing jaundice eliminating.Because Radix Salviae Miltiorrhizae is labiate Radix Salviae Miltiorrhizae rhizome, the nature and flavor hardship, be slightly cold, have effects such as the blood circulation promoting and blood stasis dispelling removing heat from blood clears away heart-fire; Radix Curcumae is the tuber of zingiberaceous plant Radix Curcumae or Rhizoma Curcumae Longae, Guangxi zedoary etc., and nature and flavor are arduous, cold, have promoting blood circulation and stopping pain, promoting QI circulation for relieving depression, and removing heat from blood clears away heart-fire, effects such as promoting the function of the gallbladder to alleviate jaundice; Radix Paeoniae Rubra is the root of cohosh Radix Paeoniae or CHUANSHAO medicine, the nature and flavor hardship, is slightly cold, and has clearing away heat and cooling blood, the stasis-dispelling and pain-killing effect; Rhizoma Imperatae is grass Herba Imperatae rhizome, and is sweet in flavor and cold in property, has cooling blood for hemostasis, and clearing away heat and promoting diuresis is let out the lung stomach clearly, the effect of dampness removing jaundice eliminating; Spica Prunellae is the fruit ear of labiate Spica Prunellae, and nature and flavor hardship, suffering, cold have clearing away liver-fire, Disperse hepatic depression, effects such as blood pressure lowering;
Selecting for use Radix Scutellariae, Rhizoma Polygoni Cuspidati, Pericarpium Granati and Radix Glycyrrhizae as messenger drug, is for heat-clearing and toxic substances removing, suppresses virus.Because Radix Scutellariae is the root of labiate Radix Scutellariae, the nature and flavor bitter cold has heat clearing and damp drying, eliminating fire and detoxication, effects such as arresting bleeding and miscarriage prevention; Rhizoma Polygoni Cuspidati is Polygonaceae arsesmart Rhizoma Polygoni Cuspidati rhizome and root, and nature and flavor hardship, cold has the analgesic therapy of invigorating blood circulation expelling wind and removing dampness, heat-clearing and toxic substances removing, preventing phlegm from forming and stopping coughing, the effect of relieving constipation by purgation; Pericarpium Granati has parasite killing, the function of relieving diarrhea with astringents; Radix Glycyrrhizae is the root and rhizome of glycyrrhizic legume, and nature and flavor are sweet, flat, have the QI invigorating invigorating middle warmer, expelling phlegm for arresting cough, and detoxifcation, relieving spasm to stop pain relaxes effects such as the property of medicine.
Effect of the present invention
The present invention's prescription is to foster healthy energy, eliminating evilly develop simultaneously with setting upright, has conditioning human body internal organs QI and blood balance, strengthen resistance of human body, quicken to produce antiviral antibody, compare with existing compositions, proved recipe, without any side effects, take back irritability happy, QI and blood and suitable, be applicable to the treatment of various hepatitis B, and treatment effective percentage and cure rate are higher.
The present invention has given sufficient confirmation to the clinical 58 routine patient treatments of selecting at random.
(1) " great three positive " patient 45 examples, adult male patient 27 examples wherein, adult female patient's 15 examples, child's 3 examples.
(2) " small three positive " patient 13 examples, male patient's 8 examples wherein, female patient 5 examples.
Diagnostic criteria:
(1) hepatitis B patient clinical symptoms: inappetence, fatigue and weak, abdominal distention, dull pain in liver etc.;
(2) liver function conventional sense: exceed following indication range for unusual:
Glutamate pyruvate transaminase (ALT/SGPT) 0-50U/l
Glutamic oxaloacetic transaminase, GOT (AST/SGOT) 0-40U/l
Gamma glutamyl transpeptidase (the 0-40U/l of γ-GT)
Alkali phosphatase (ALT/AKP) 30-140U/l
In addition, severe patient's albumin is low, and globulin increases, and A/G cholecystitis occurs less than 1, diseases such as arthritis;
(3) hepatitis B three is: HB
SAg/HB
SAb, HB
eA
g/ HB
eAb, HB
cAb/HB
cAb-IgM normal person is all negative, but hepatitis B patient has following situation mostly:
" great three positive " patient: hepatitis B three is middle HB
SAg, HB
eA
g, HB
cAb all is positive, and strong infectiousness is arranged, and falls ill mostly to be acute hepatitis B in six months;
" small three positive " patient: hepatitis B three is middle HB
SAg, HB
eA
g, HB
cAb all is positive, and weak infectiousness is arranged;
HB
SThe Ab individual event positive illustrates that patient has entered convalescence.
Therapeutic Method:
(1) " great three positive " patient takes 750ml (pair) every day, divides and takes for early, middle and late three times, take 250ml at every turn, took continuously first course of treatment 20 days, whenever taking 10 days later on is a course of treatment, a course of treatment was taken at every interval in 10 days, took 90 pairs totally 8 courses of treatment.
(2) " small three positive " patient, 750ml every day (pair) divides and takes for early, middle and late three times, takes 250ml at every turn, and whenever taking 10 days is a course of treatment, and a course of treatment was taken at every interval in ten days again, took altogether and took 60 pairs 6 courses of treatment.
(3) child's " great three positive " patient takes 450ml (3/5ths pairs) every day, divides and takes for early, middle and late three times, take 150ml at every turn, took continuously first course of treatment 20 days, whenever taking 10 days later on is a course of treatment, a course of treatment was taken at every interval in ten days, took 54 pairs totally 8 courses of treatment.
Curative effect is judged:
Produce effects: patient's clinical symptoms all disappears, and the every index of blood drawing chemical examination liver function is normal, and chemical examination hepatitis B three is HB
SAb is positive;
Take a turn for the better: clinical symptoms all disappears, and the every index of blood drawing chemical examination liver function is normal, and chemical examination hepatitis B three is that the patient does not enter convalescence, 20 pairs of taking medicine again, later HB
SAb is positive.
Therapeutic effect:
" great three positive " patient takes after the present invention's 30 pairs, and clinical symptoms all disappears, and takes after 60 pairs, and the patient feels as healthy people, and after 90 pairs of taking medicine, 88.9% patient's hepatitis B three is HB
SAb is positive, and does not enter the reconvalescent and takes medicine after 20 pairs HB again
SAb all is positive.Produce effects 40 examples as a result, obvious effective rate is 88.9%, 5 examples that take a turn for the better, improvement rate is 11.1%, invalid is 0, total effective rate 100%.
" small three positive " patient used after the present invention three courses of treatment, and clinical symptoms all disappears, and the every index of blood drawing chemical examination liver function is normal, takes medicine after 6 courses of treatment, and patient's hepatitis B three is HB
sAb all is positive, produce effects 13 examples as a result, and invalid is 0 example, obvious effective rate and total effective rate are 100%.
The specific embodiment
Embodiment 1:
With Radix Astragali 10 grams, Radix Codonopsis 10 grams, Rhizoma Atractylodis Macrocephalae (parched) 10 grams, Radix Angelicae Sinensis 10 grams, Radix Paeoniae Alba 10 grams, Rhizoma Cyperi 10 grams, the Radix Rehmanniae 10 grams, Rhizoma Chuanxiong 3 grams, Radix Salviae Miltiorrhizae 5 grams, Radix Curcumae 6 grams, Radix Paeoniae Rubra 3 grams, Spica Prunellae 10 grams, Rhizoma Imperatae 15 grams, Radix Scutellariae 3 grams, Rhizoma Polygoni Cuspidati 10 grams, Pericarpium Granati 15 grams, Radix Glycyrrhizae 2 grams are removed impurity, clean the back mixing and water adding and cross the powder decoction, heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; Above-mentioned recrement is added water cross powder and decoct to heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; For the second time recrement adds water and crosses powder and decoct again, heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid to leach, and mixes the medicinal liquid that leaches for three times to such an extent that about 750ml medicinal liquid is an auxiliary medicine.
Embodiment 2
With Radix Astragali 20 grams, Radix Codonopsis 15 grams, Rhizoma Atractylodis Macrocephalae (parched) 10 grams, Radix Angelicae Sinensis 10 grams, Radix Paeoniae Alba 15 grams, Rhizoma Cyperi 10 grams, the Radix Rehmanniae 10 grams, Rhizoma Chuanxiong 10 grams, Radix Salviae Miltiorrhizae 10 grams, Radix Curcumae 10 grams, Radix Paeoniae Rubra 10 grams, Spica Prunellae 10 grams, Rhizoma Imperatae 30 grams, Radix Scutellariae 10 grams, Rhizoma Polygoni Cuspidati 15 grams, Pericarpium Granati 10 grams, Radix Glycyrrhizae 10 grams, attached decontamination, clean the back mixing and water adding and cross the powder decoction, heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; Above-mentioned recrement is added water cross powder and decoct to heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; For the second time recrement adds water and crosses powder and decoct again, heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid to leach, and mixes the medicinal liquid that leaches for three times to such an extent that about 750ml medicinal liquid is an auxiliary medicine.
Embodiment 3
With Radix Astragali 30 grams, Radix Codonopsis 30 grams, Rhizoma Atractylodis Macrocephalae (parched) 15 grams, Radix Angelicae Sinensis 15 grams, Radix Paeoniae Alba 15 grams, Rhizoma Cyperi 15 grams, the Radix Rehmanniae 30 grams, Rhizoma Chuanxiong 10 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Curcumae 12 grams, Radix Paeoniae Rubra 15 grams, Spica Prunellae 15 grams, Rhizoma Imperatae 30 grams, Radix Scutellariae 10 grams, Rhizoma Polygoni Cuspidati 30 grams, Pericarpium Granati 15 grams, Radix Glycyrrhizae 10 grams are removed impurity, clean the back mixing and water adding and cross the powder decoction, heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; Above-mentioned recrement is added water cross powder and decoct to heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach; For the second time recrement adds water and crosses powder and decoct again, heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid to leach, and mixes the medicinal liquid that leaches for three times to such an extent that about 750ml medicinal liquid is an auxiliary medicine.
Claims (3)
1, a kind of Chinese medicine composition for the treatment of hepatitis B is characterized in that it is to be made by the raw material of following weight portion:
Radix Astragali 10～30 Radix Codonopsis 10～30 Rhizoma Atractylodis Macrocephalae (parched)s 10～15 Radix Angelicae Sinensis 10～15
Radix Paeoniae Alba 10～15 Rhizoma Cyperis 10～15 Radix Rehmanniae 10～30 Rhizoma Chuanxiongs 3～10
Radix Salviae Miltiorrhizae 5～15 Radix Curcumaes 6～12 Radix Paeoniae Rubras 3～15 Spica Prunellaes 10～15
Rhizoma Imperatae 15～30 Radix Scutellariaes 3～10 Rhizoma Polygoni Cuspidati 10～30 Pericarpium Granatis 10～15
Radix Glycyrrhizae 2～10.
2, the Chinese medicine composition of treatment hepatitis B according to claim 1 is characterized in that it is to be made by the raw material of following weight portion:
Radix Astragali 20 Radix Codonopsis 15 Rhizoma Atractylodis Macrocephalae (parched)s 10 Radix Angelicae Sinensis 10 Radix Paeoniae Alba 15 Rhizoma Cyperis 10
The Radix Rehmanniae 10 Rhizoma Chuanxiongs 10 Radix Salviae Miltiorrhizaes 10 Radix Curcumaes 10 Radix Paeoniae Rubras 10 Spica Prunellaes 10
Rhizoma Imperatae 30 Radix Scutellariaes 10 Rhizoma Polygoni Cuspidati 15 Pericarpium Granatis 15 Radix Glycyrrhizae 10.
3, the preparation method of the Chinese medicine composition of treatment hepatitis B according to claim 1 is characterized in that comprising the steps:
(1) each material medicine is removed impurity;
(2) add water by described mixed and cross the powder decoction, heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach;
(3) above-mentioned recrement is added water and cross the powder decoction, heat and after 100 ℃, boiled 20～30 minutes, make medicinal liquid and leach;
(4) for the second time recrement adds water and crosses powder and decoct, and heats and boils 20～30 minutes after 100 ℃, makes medicinal liquid to leach;
(5) medicinal liquid that leaches for three times is mixed, get final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410014021 CN1223374C (en) | 2004-02-06 | 2004-02-06 | Chinese medicinal composition for treating hepatitis B |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200410014021 CN1223374C (en) | 2004-02-06 | 2004-02-06 | Chinese medicinal composition for treating hepatitis B |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1557396A CN1557396A (en) | 2004-12-29 |
| CN1223374C true CN1223374C (en) | 2005-10-19 |
Family
ID=34351243
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200410014021 Expired - Fee Related CN1223374C (en) | 2004-02-06 | 2004-02-06 | Chinese medicinal composition for treating hepatitis B |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1223374C (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100409865C (en) * | 2006-05-30 | 2008-08-13 | 夏金陵 | Compound medicine for treating hepatitis B |
| CN100356968C (en) * | 2006-07-06 | 2007-12-26 | 刘海刚 | Chinese-western medicine synergistic medicine medicinal composition containing dicyclic alcohol |
| CN100353994C (en) * | 2006-07-06 | 2007-12-12 | 钱欣 | Synergistic medicinal composition |
| CN100345586C (en) * | 2006-08-17 | 2007-10-31 | 汪敏 | Chinese traditional medicine and western medicine composition for treating hepatitis |
| CN101361810B (en) * | 2008-10-07 | 2011-01-12 | 李友林 | Traditional Chinese medicine combination for treating virus lower respiratory tract infection and preparation method thereof |
| CN101502631B (en) * | 2009-03-18 | 2010-10-13 | 张砚 | Synergistic medicament composition containing Aolamite and Chinese medicine extract |
| CN101979070B (en) * | 2010-10-27 | 2011-12-28 | 苏桂华 | Chinese medicament for treating hepatitis B |
| CN102631384B (en) * | 2012-04-28 | 2014-03-12 | 中国科学院武汉病毒研究所 | Application of pomegranate in preparing medicament for treating or preventing hepatitis B virus infection |
| CN106420971A (en) * | 2016-12-13 | 2017-02-22 | 蓝庆流 | Traditional Chinese medicine composition for treating hepatitis |
-
2004
- 2004-02-06 CN CN 200410014021 patent/CN1223374C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1557396A (en) | 2004-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wang et al. | Diagnosis and treatment of novel coronavirus pneumonia based on the theory of traditional Chinese medicine | |
| CN101129817B (en) | Chinese medicine formulation for treating hypertension and method of producing the same | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN1485083A (en) | Capsule for thyroid cancer / tumor and lymph node | |
| CN1131046C (en) | Chinese medicine for treating baby pneumonia | |
| CN1223374C (en) | Chinese medicinal composition for treating hepatitis B | |
| CN101284101A (en) | Chinese traditional medicine for curing fatty liver and hyperlipemia | |
| CN104587298A (en) | Traditional Chinese medicinal composition for treating pulmonary abscess | |
| CN1903224A (en) | Method for comprehensive processing and preparing of traditional Chinese medicine | |
| CN1692939A (en) | Traditional Chinese medicine pill for treating hepatitis B, and its prepn. method | |
| CN1286490C (en) | Anti-inflammatory clear belt soup | |
| CN102335336A (en) | Traditional Chinese medicine for treating lupus sebaceus | |
| CN1063954C (en) | Chinese patent medicine-powder preparation for curing hepatitis B | |
| CN1052889C (en) | Chinese proprietary for curing hepatitis | |
| CN1066628C (en) | Medicine for chronic hepatitis B and its preparation | |
| CN101199749A (en) | Chinese medicine for treating AIDS | |
| CN105687579A (en) | Traditional Chinese medicine composition for treating bronchial asthma | |
| CN1055220C (en) | Chinese drug for treatment of hemiplegia | |
| CN104189368A (en) | Traditional Chinese medicinal composition for treating spleen and stomach diseases and preparation method thereof | |
| CN1294980C (en) | Medicine for treating liver disease | |
| CN1094057C (en) | Liver ascites treating medicine | |
| CN1054753C (en) | Tianlingkangfu pill for recovery | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN103877504A (en) | Formula and preparation method of traditional Chinese herbal medicine for treating hepatitis B and preparation method thereof | |
| CN1352966A (en) | Medicine for treating tracheitis and asthma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |